Impact of Intravenous, Perioperative-Administrated Lidocaine on Postoperative Serum Levels of Endogenous Opioids in Children

Author(s): Barbara Kościelniak-Merak, Ilona Batko, Krzysztof Kobylarz, Krystyna Sztefko, Magdalena Kocot-Kępska, Przemysław J. Tomasik*.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 30 , 2019


Abstract:

Background: Endogenous opioids are neuropeptides involved in pain-relieving processes. In the periphery, they are synthesised and stored in cells of the immune system.

Objective: In the current study, we describe the influence of perioperative, intravenous (i.v.) lidocaine infusion in children on postoperative, serum endogenous opioid concentrations in children.

Methods: Forty-four children undergoing major spinal surgery were enrolled in the cohort study. They were divided into two groups: group A (n = 21) generally anesthetised with fentanyl, propofol, rocuronium, a mixture of oxygen/air/sevoflurane and with analgetics and co-analgetics: morphine, acetaminophen, metamizole, gabapentin, dexamethason and group B (n = 23) where, in addition to the above-described general anesthesia, patients were given i.v. lidocaine as a co-analgesic. We also recruited 20 healthy age- and gender-matched children (group C). We measured endogenous opioid levels in serum using immunoenzymatic methods. We evaluated postoperative pain intensity using a numerical or visual pain scale and demand for morphine.

Results: The levels of measured endogenous opioids were similar in the control and in the studied groups before surgery. We noted that group B patients had lower pain intensity when compared to group A subjects. In group B, the elevated serum concentrations of β -endorphin, enkephalin and dynorphin in the postoperative period were reported. We also observed that the levels of endogenous opioids negatively correlated with morphine requirements and positively correlated with lidocaine concentration.

Conclusion: Multidrug pain management including lidocaine seems to be more efficient than models without lidocaine. The endogenous opioid system should be considered as a novel target for pain relief therapy in children.

Keywords: Postoperative pain, spine surgery, endorphin, enkephalin, dynorphin, opioids.

[1]
Benarroch EE. Endogenous opioid systems: current concepts and clinical correlations. Neurology 2012; 79(8): 807-14.
[http://dx.doi.org/10.1212/WNL.0b013e3182662098] [PMID: 22915176]
[2]
Chaturvedi K. Opioid peptides, opioid receptors and mechanism of down regulation. Indian J Exp Biol 2003; 41: 5-13.
[3]
Smith EM. Opioid peptides in immune cells. Adv Exp Med Biol 2003; 521: 51-68.
[PMID: 12617564]
[4]
Mousa SA, Shakibaei M, Sitte N, Schäfer M, Stein C. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 2004; 145(3): 1331-41.
[http://dx.doi.org/10.1210/en.2003-1287] [PMID: 14630714]
[5]
Hook S, Camberis M, Prout M, et al. Preproenkephalin is a Th2 cytokine but is not required for Th2 differentiation in vitro. Immunol Cell Biol 1999; 77(5): 385-90.
[http://dx.doi.org/10.1046/j.1440-1711.1999.00842.x] [PMID: 10540203]
[6]
LaMendola J, Martin SK, Steiner DF. Expression of PC3, carboxypeptidase E and enkephalin in human monocyte-derived macrophages as a tool for genetic studies. FEBS Lett 1997; 404(1): 19-22.
[http://dx.doi.org/10.1016/S0014-5793(97)00078-1] [PMID: 9074629]
[7]
Vindrola O, Mayer AM, Citera G, Spitzer JA, Espinoza LR. Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages. Parallel changes with proenkephalin-derived peptides induced by LPS in vivo. Neuropeptides 1994; 27(4): 235-44.
[http://dx.doi.org/10.1016/0143-4179(94)90004-3] [PMID: 7808596]
[8]
Chadzinska M, Starowicz K, Scislowska-Czarnecka A, et al. Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice. Immunol Lett 2005; 101(2): 185-92.
[http://dx.doi.org/10.1016/j.imlet.2005.05.009] [PMID: 15979727]
[9]
Gupta A, Kaur K, Sharma S, Goyal S, Arora S, Murthy RSR. Clinical aspects of acute post-operative pain management & its assessment. J Adv Pharm Technol Res 2010; 1(2): 97-108.
[PMID: 22247838]
[10]
Pogatzki-Zahn EM, Segelcke D, Schug SA. Postoperative pain-from mechanisms to treatment. Pain Rep 2017; 2(2) e588
[http://dx.doi.org/10.1097/PR9.0000000000000588] [PMID: 29392204]
[11]
Machelska H. Targeting of opioid-producing leukocytes for pain control. Neuropeptides 2007; 41(6): 355-63.
[http://dx.doi.org/10.1016/j.npep.2007.06.001] [PMID: 17640727]
[12]
Holden JE, Jeong Y, Forrest JM. The endogenous opioid system and clinical pain management. AACN Clin Issues 2005; 16(3): 291-301.
[PMID: 16082232]
[13]
Sehgal N, Smith HS, Manchikanti L. Peripherally acting opioids and clinical implications for pain control. Pain Physician 2011; 14(3): 249-58.
[PMID: 21587328]
[14]
Zealand College of Anaesthetists N, of Pain Medicine F.. Acute Pain Management: Scientific Evidence Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine 2010.
[15]
Gordh T, Gordh TE, Lindqvist K. Lidocaine: the origin of a modern local anesthetic. 1949. Anesthesiology 2010; 113(6): 1433-7.
[http://dx.doi.org/10.1097/ALN.0b013e3181fcef48] [PMID: 21068652]
[16]
Lauretti GR. Mechanisms of analgesia of intravenous lidocaine. Rev Bras Anestesiol 2008; 58: 280-6.
[17]
Marret E, Rolin M, Beaussier M, Bonnet F. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg 2008; 95(11): 1331-8.
[http://dx.doi.org/10.1002/bjs.6375] [PMID: 18844267]
[18]
Fitzpatrick BM, Mullins ME. Intravenous lidocaine for the treatment of acute pain in the emergency department. Clin Exp Emerg Med 2016; 3(2): 105-8.
[http://dx.doi.org/10.15441/ceem.15.103] [PMID: 27752626]
[19]
Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995; 332(25): 1685-90.
[http://dx.doi.org/10.1056/NEJM199506223322506]
[20]
Stein C. Opioid receptors on peripheral sensory neurons. Adv Exp Med Biol 2003; 521: 69-76.
[PMID: 12617565]
[21]
Lee JY, Jo YY. Attention to postoperative pain control in children. Korean J Anesthesiol 2014; 66(3): 183-8.
[http://dx.doi.org/10.4097/kjae.2014.66.3.183] [PMID: 24729838]
[22]
Stein C, Lang LJ. Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol 2009; 9(1): 3-8.
[http://dx.doi.org/10.1016/j.coph.2008.12.009] [PMID: 19157985]
[23]
Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008; 11(2)(Suppl.): S105-20.
[PMID: 18443635]
[24]
Wardhan R, Chelly J. Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy. F1000 Res 2017; 6: 2065.
[http://dx.doi.org/10.12688/f1000research.12286.1] [PMID: 29225793]
[25]
Vigneault L, Turgeon AF, Côté D, et al. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anesth Can d’anesthésie 2011; 58: 22-37.
[http://dx.doi.org/10.1007/s12630-010-9407-0]
[26]
Sun Y, Li T, Wang N, Yun Y, Gan TJ. Perioperative systemic lidocaine for postoperative analgesia and recovery after abdominal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum 2012; 55(11): 1183-94.
[http://dx.doi.org/10.1097/DCR.0b013e318259bcd8] [PMID: 23044681]
[27]
Weibel S, Jelting Y, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults. Cochrane Database Syst Rev 2018; 6 CD009642
[http://dx.doi.org/10.1002/14651858.CD009642.pub3] [PMID: 29864216]
[28]
Eipe N, Gupta S, Penning J. Intravenous lidocaine for acute pain: an evidence-based clinical update. BJA Educ 2016; 16: 292-8.
[http://dx.doi.org/10.1093/bjaed/mkw008]
[29]
de Souza MF, Kraychete DC. The analgesic effect of intravenous lidocaine in the treatment of chronic pain: a literature review. Rev Bras Reumatol 2014; 54(5): 386-92.
[http://dx.doi.org/10.1016/j.rbr.2014.01.010] [PMID: 25627303]
[30]
Soto G, Naranjo González M, Calero F. Intravenous lidocaine infusion. Rev Esp Anestesiol Reanim 2018; 65(5): 269-74.
[http://dx.doi.org/10.1016/j.redar.2018.01.004] [PMID: 29496229]
[31]
Foroughi M. The miracle of Lidocaine: second look with cellular and molecular perspectives. J Cell Mol Anesth 2018; 3: 1-2.
[32]
Yang SY, Kang H, Choi GJ, et al. Efficacy of intraperitoneal and intravenous lidocaine on pain relief after laparoscopic cholecystectomy. J Int Med Res 2014; 42(2): 307-19.
[http://dx.doi.org/10.1177/0300060513505493] [PMID: 24648482]
[33]
Hargreaves KM, Dionne RA, Mueller GP, Goldstein DS, Dubner R. Naloxone, fentanyl, and diazepam modify plasma beta-endorphin levels during surgery. Clin Pharmacol Ther 1986; 40(2): 165-71.
[http://dx.doi.org/10.1038/clpt.1986.159] [PMID: 3731680]
[34]
Hargreaves KM, Dionne RA, Mueller GP. Plasma beta-endorphin-like immunoreactivity, pain and anxiety following administration of placebo in oral surgery patients. J Dent Res 1983; 62(11): 1170-3.
[http://dx.doi.org/10.1177/00220345830620111601] [PMID: 6580319]
[35]
Helander EM, Menard BL, Harmon CM, et al. Multimodal analgesia, current concepts, and acute pain considerations. Curr Pain Headache Rep 2017; 21(1): 3.
[http://dx.doi.org/10.1007/s11916-017-0607-y] [PMID: 28132136]
[36]
Kapitzke D, Vetter I, Cabot PJ. Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control. Ther Clin Risk Manag 2005; 1(4): 279-97.
[PMID: 18360571]
[37]
Dubois M, Pickar D, Cohen M, Gadde P, Macnamara TE, Bunney WE. Effects of fentanyl on the response of plasma beta-endorphin immunoreactivity to surgery. Anesthesiology 1982; 57(6): 468-72.
[http://dx.doi.org/10.1097/00000542-198212000-00006] [PMID: 6293344]
[38]
Cork RC, Hameroff SR, Weiss JL. Effects of halothane and fentanyl anesthesia on plasma beta-endorphin immunoreactivity during cardiac surgery. Anesth Analg 1985; 64(7): 677-80.
[http://dx.doi.org/10.1213/00000539-198507000-00005] [PMID: 3160261]
[39]
Bronstein DM, Przewlocki R, Akil H. Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res 1990; 519(1-2): 102-11.
[http://dx.doi.org/10.1016/0006-8993(90)90066-K] [PMID: 2144463]
[40]
Rivat C, Ballantyne J. The dark side of opioids in pain management: basic science explains clinical observation. Pain Rep 2016; 1(2)e570
[http://dx.doi.org/10.1097/PR9.0000000000000570] [PMID: 29392193]
[41]
Simonnet G, Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport 2003; 14(1): 1-7.
[http://dx.doi.org/10.1097/00001756-200301200-00001] [PMID: 12544821]
[42]
DuPen A, Shen D, Ersek M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag Nurs 2007; 8(3): 113-21.
[http://dx.doi.org/10.1016/j.pmn.2007.02.004] [PMID: 17723928]
[43]
Silverman SM. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician 2009; 12(3): 679-84.
[PMID: 19461836]
[44]
Tsai PS, Buerkle H, Huang LT, Lee TC, Yang LC, Lee JH. Lidocaine concentrations in plasma and cerebrospinal fluid after systemic bolus administration in humans. Anesth Analg 1998; 87(3): 601-4.
[PMID: 9728837]
[45]
Finholt DA, Stirt JA, DiFazio CA, Moscicki JC. Lidocaine pharmacokinetics in children during general anesthesia. Anesth Analg 1986; 65(3): 279-82.
[http://dx.doi.org/10.1213/00000539-198603000-00010] [PMID: 3954094]
[46]
Kim K-T, Cho D-C, Sung J-K, et al. Intraoperative systemic infusion of lidocaine reduces postoperative pain after lumbar surgery: a double-blinded, randomized, placebo-controlled clinical trial. Spine J 2014; 14(8): 1559-66.
[http://dx.doi.org/10.1016/j.spinee.2013.09.031] [PMID: 24216403]
[47]
Farag E, Ghobrial M, Sessler DI, et al. Effect of perioperative intravenous lidocaine administration on pain, opioid consumption, and quality of life after complex spine surgery. Anesthesiology 2013; 119(4): 932-40.
[http://dx.doi.org/10.1097/ALN.0b013e318297d4a5] [PMID: 23681143]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 30
Year: 2019
Page: [3209 - 3215]
Pages: 7
DOI: 10.2174/1381612825666190718153209
Price: $58

Article Metrics

PDF: 21
HTML: 2
EPUB: 1
PRC: 1

Special-new-year-discount